戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tients referred for post-Chikungunya chronic musculoskeletal pain).
2 ion marked by gross joint laxity and chronic musculoskeletal pain.
3 included rash, lightheadedness, fatigue, and musculoskeletal pain.
4 e regarding a variety of causes of childhood musculoskeletal pain.
5 ay be recommended for general cancer pain or musculoskeletal pain.
6 etabolic dysregulation, cancer cachexia, and musculoskeletal pain.
7 peractivity disorder (ADHD), depression, and musculoskeletal pain.
8 multi-symptom illness that commonly includes musculoskeletal pain.
9 sociated with increased incidence of chronic musculoskeletal pain.
10 ticipants were sedentary adults with chronic musculoskeletal pain.
11 ged 60 to 95 years with at least 3 months of musculoskeletal pain.
12 re concerned about career-ending or limiting musculoskeletal pain.
13 pression, and regional or widespread chronic musculoskeletal pain.
14  management support intervention for chronic musculoskeletal pain.
15 mitations and higher incidence of multijoint musculoskeletal pain.
16 , 49% had poor functional status and 76% had musculoskeletal pain.
17  primary care patients with improved chronic musculoskeletal pain.
18 eatures of neuropathic pain in subjects with musculoskeletal pain.
19 reases in pH and plays a significant role in musculoskeletal pain.
20 tood, despite being a key symptom of chronic musculoskeletal pain.
21 le of HTR2A in the genetic predisposition to musculoskeletal pain.
22 -related mortality, while increasing RDI and musculoskeletal pain.
23 nic acid were pyrexia, myalgia, and bone and musculoskeletal pain.
24 improve patient-centered outcomes in chronic musculoskeletal pain.
25 new light on treatments for osteoporosis and musculoskeletal pain.
26 headache, hyperlipidemia, transaminites, and musculoskeletal pains.
27                                              Musculoskeletal pain (1.50 vs 1.72; p=0.0006) and vagina
28 ter treatment-related adverse events such as musculoskeletal pain (14 in the intervention group vs 0
29 ain (3.2%), arthritis pain (2.0%), and other musculoskeletal pain (2.0%).
30 not available, and 12% (8-19), respectively; musculoskeletal pain 26% (19-33), 39% (23-57), and 86% (
31  six [<1%] of 1400 in the control group) and musculoskeletal pain (29 [1%] vs 13 [1%]).
32  were general symptoms (324 [40%] patients), musculoskeletal pain (303 [38%]), headache (278 [35%]),
33 he two groups in the frequency of short-term musculoskeletal pain (486 [41%] of 1188 adverse events i
34 se of side effects (neutropenia, 6 patients; musculoskeletal pain, 5 patients; thrombocytosis, 4 pati
35  rheumatologist for post-Chikungunya chronic musculoskeletal pain, 73 of them were diagnosed with cla
36                                              Musculoskeletal pain affects nearly half of all adults,
37 y and use of lifts were associated with less musculoskeletal pain among critical-care nurses.
38 astrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia.
39 brile syndrome characterized by debilitating musculoskeletal pain and arthritis.
40 lgia is characterized by chronic, widespread musculoskeletal pain and associated fatigue, sleep distu
41                                              Musculoskeletal pain and dysfunction are found in 50% to
42 havioural and neural changes associated with musculoskeletal pain and fatigue during reward and loss
43 ignificant relationship was observed between musculoskeletal pain and high-sensitivity C-reactive pro
44 an increased association between obesity and musculoskeletal pain and increased fracture risk.
45 nsmitted alphavirus that causes debilitating musculoskeletal pain and inflammation and can persist fo
46           Obesity is associated with chronic musculoskeletal pain and is a risk factor for disability
47 participants' understanding of their chronic musculoskeletal pain and its management in a specialist
48 ere used to examine the associations between musculoskeletal pain and lift variables, controlling for
49 yndrome (FMS) is characterized by widespread musculoskeletal pain and lowered pain threshold.
50                                  We assessed musculoskeletal pain and pain intensity of the lower bac
51 rse events included hand-foot skin reaction, musculoskeletal pain, and fatigue.
52 y still shows prolonged symptoms of fatigue, musculoskeletal pain, and perceived cognitive impairment
53     A visual analog scale was used to assess musculoskeletal pain, and quality of life was evaluated
54 the TASQ arm included GI disorders, fatigue, musculoskeletal pains, and elevations of pancreatic and
55 on in awareness of someone outside work with musculoskeletal pain; and more than ten-fold variation i
56                                              Musculoskeletal pain appeared to be the most common pain
57 r chronic opioid use among patients with new musculoskeletal pain are not fully understood.
58 orticosteroids injected for the treatment of musculoskeletal pain are systemically absorbed and can a
59  (NSPS) such as abdominal pain, headache and musculoskeletal pain are widespread in the community, an
60                       Moderately troublesome musculoskeletal pain at age 17.8 years was reported most
61           A report of 2 or more locations of musculoskeletal pain at baseline was associated with gre
62 ased risk of at least moderately troublesome musculoskeletal pain at the shoulder (odds ratio [OR] 1.
63 ages 18-64 diagnosed with non-trauma related musculoskeletal pain between January 1, 2008 and Decembe
64                    Exploratory outcomes were musculoskeletal pain, bladder symptoms, gynaecological s
65 eduction in various forms of pain, including musculoskeletal pain, bone pain, headache, arthralgia, a
66                                        Since musculoskeletal pain can have varying levels of severity
67 rmine whether the prevalence of work-related musculoskeletal pain, cancer, and other medical conditio
68           Shoulder joint is a common site of musculoskeletal pain caused, among other things, by rota
69 etal pain and its management in a specialist musculoskeletal pain clinic.
70                                      Chronic musculoskeletal pain (CMP) is a significant burden for P
71                            Chronic multisite musculoskeletal pain (CMP) is common and highly morbid.
72 tributes to the higher prevalence of chronic musculoskeletal pain compared with pain of cutaneous ori
73 g image-guided corticosteroid injections for musculoskeletal pain compared with the general populatio
74 were statistically significant reductions in musculoskeletal pain concerns at all points.
75 ting HR minus posttest HR) were measured and musculoskeletal pain concerns, during and after the test
76 oromandibular joint disorder (TMD), a common musculoskeletal pain condition.
77                         The 401 patients had musculoskeletal pain diagnoses, moderate or greater pain
78 ile fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain disorder in children and adolescent
79                                     Numerous musculoskeletal pain disorders are based in dysfunction
80              JH represents a risk factor for musculoskeletal pain during adolescence, comprising a sp
81 al trial among cancer survivors with chronic musculoskeletal pain, electroacupuncture and auricular a
82 chronic disorder characterized by widespread musculoskeletal pain, fatigue and tenderness and closely
83 a-like symptoms including chronic widespread musculoskeletal pain, fatigue, and/or gait impairment in
84 scle is predicted to favor the generation of musculoskeletal pain following injury.
85 but no current evidence of disease, reported musculoskeletal pain for at least 3 months, and self-rep
86 1 eligible patients with high-impact chronic musculoskeletal pain from 4 geographically diverse healt
87 ar veterans, we report veterans with chronic musculoskeletal pain have smaller gray matter volumes in
88                                              Musculoskeletal pain in childhood due either to underlyi
89 hat causes acute fever and acute and chronic musculoskeletal pain in humans.
90 COX-2 inhibitors when used for arthritis and musculoskeletal pain in patients without coronary artery
91 g opioid-naive patients with newly diagnosed musculoskeletal pain in the knee, neck, low back, and/or
92                                      Chronic musculoskeletal pain including knee osteoarthritis (OA)
93  using the visual analog scale, categorizing musculoskeletal pain into lower back pain, lower extremi
94                                              Musculoskeletal pain is a common condition, raising the
95                                   Widespread musculoskeletal pain is a poorly understood but common p
96                                              Musculoskeletal pain is a significantly common clinical
97                                      Chronic musculoskeletal pain is among the most prevalent, costly
98                                      Chronic musculoskeletal pain is common in older adults but the n
99                                   Widespread musculoskeletal pain is frequent among community-dwellin
100                                              Musculoskeletal pain is more common among healthcare wor
101                                      Chronic musculoskeletal pain is the leading cause of disability
102                                          The musculoskeletal pain lasted longer than 7 days in five p
103                Tramadol is an alternative to musculoskeletal pain management, particularly in patient
104 even percent of surgeons were concerned that musculoskeletal pain may shorten their career.
105 oking, self-rated health, arthritis, chronic musculoskeletal pain, migraines, headaches, fatigue, and
106 ween groups, including nausea, anorexia, and musculoskeletal pain, most of mild severity.
107   The most common adverse events were cough, musculoskeletal pain, nasopharyngitis, headache, back pa
108 usly treated Lyme disease but had persistent musculoskeletal pain, neurocognitive symptoms, or dysest
109 ne [<1%]), vomiting (13 [11%] vs one [<1%]), musculoskeletal pain (none vs ten [8%]), anaemia (39 [33
110 ly reported adverse events were headache and musculoskeletal pain, observed in 8 patients.
111                 We recruited 703 adults with musculoskeletal pain of at least 3 mo duration between A
112 e in 250 patients with chronic (>/=3 months) musculoskeletal pain of at least moderate intensity (Bri
113 flammation, all of which may produce chronic musculoskeletal pain, often pose challenges for current
114  There were 32 adverse events (most commonly musculoskeletal pain or discomfort and mild hypoglycemia
115 events and the most frequently reported were musculoskeletal pain or discomfort from prone positionin
116 lower income and educational attainment, and musculoskeletal pain or headache.
117  of urologists have experienced work-related musculoskeletal pain or injury at some point in their ca
118                                       Opioid musculoskeletal pain overprescribing was widespread in t
119 tly more severe physical symptoms, including musculoskeletal pain (P = .01), vaginal problems (P < .0
120 nopuasal women with BC who had self-reported musculoskeletal pain related to AIs.
121 uroinflammation in male rats in the model of musculoskeletal pain related to GWI.
122 ms underlying the high prevalence of chronic musculoskeletal pain remain poorly understood, in part b
123 al (Stepped Care for Affective Disorders and Musculoskeletal Pain [SCAMP]) conducted at 6 community-b
124                 The Short form of the Orebro Musculoskeletal Pain Screening Questionnaire (OMPSQ-shor
125             JPFS is characterized by chronic musculoskeletal pain, sleep disturbance, fatigue, and di
126 e the efficacy of NGF inhibition for chronic musculoskeletal pain states.
127                   The presenting symptoms of musculoskeletal pain, swelling, and stiffness are common
128 year forwarding our understanding of chronic musculoskeletal pain syndromes in children.
129         Adolescents with severe obesity have musculoskeletal pain that limits their physical function
130  association between joint hypermobility and musculoskeletal pains, the latter occurring in the absen
131 lity and in the reduction of walking-related musculoskeletal pain up to 2 years after surgery.
132 ACWR and injury, defined as patient-reported musculoskeletal pain, using generalized additive mixed m
133                                              Musculoskeletal pain varied significantly by job descrip
134  gray matter volume in patients with chronic musculoskeletal pain versus healthy controls, as well as
135 distinct brain structures underlying chronic musculoskeletal pain, visceral pain, and headaches.
136                                              Musculoskeletal pain was assessed by three types of meas
137                                   Widespread musculoskeletal pain was defined as pain in the upper an
138                                              Musculoskeletal pain was evaluated by questionnaire at a
139                                      Bone or musculoskeletal pain was reported in 10.4% of controls a
140                                The degree of musculoskeletal pain was slightly lower in the exercise
141           In thirty individuals with chronic musculoskeletal pain, we assessed markers of peripheral
142 different symptoms, mostly fatigue (n = 57), musculoskeletal pain/weakness (n = 49), and abdominal pa
143  replicates key temporal aspects of clinical musculoskeletal pain while allowing quantification of ne
144  multicenter study, adults with a history of musculoskeletal pain who underwent imaging-guided intra-
145  years is not associated with an increase in musculoskeletal pain with age, and there may be a modera
146 s (eg, gastroesophageal irritation or severe musculoskeletal pain) with longer-term benefits in reduc
147 outpatient visit or emergency room visit for musculoskeletal pain within 30 days of the initial diagn
148 oint disorders are a common cause of chronic musculoskeletal pain worldwide.

 
Page Top